Literature DB >> 28871063

Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis.

Michelle Laneuville1, Joy Ding2, Michel Shamy2, Cheemun Lum2, Dar Dowlatshahi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28871063     DOI： 10.1212/WNL.0000000000004337

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

2.  Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

3.  Ipsilateral Reversible Cerebral Vasculopathy Secondary to Carotid Artery Revascularization: A Case Report.

Authors:  Aaron Shoskes; Naresh Mullaguri; Meghan Purohit; Pravin George; Christopher Ryan Newey
Journal:  Neurohospitalist       Date:  2020-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.